Pharming Group NV (PHAR)

Currency in EUR
1.331
+0.031(+2.38%)
Closed·

Pharming Group (PHAR) Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral

Technical Indicators

Buy

Moving Averages

Neutral

Summary:Neutral

Moving Averages:NeutralBuy: (6)Sell: (6)
Technical Indicators:BuyBuy: (5)Sell: (3)

Technical Indicators

Summary: BuyBuy: 5Neutral: 2Sell: 3
Feb 15, 2026 01:35AM GMT
Name
Value
Action
RSI(14)50.233Neutral
STOCH(9,6)54.835Neutral
STOCHRSI(14)100Overbought
MACD(12,26)-0.011Sell
ADX(14)39.491Sell
Williams %R-27.941Buy
CCI(14)51.0149Buy
ATR(14)0.0138Less Volatility
Highs/Lows(14)0.007Buy
Ultimate Oscillator51.541Buy
ROC-1.334Sell
Bull/Bear Power(13)0.02Buy

Moving Averages

Summary: NeutralBuy: 6Sell: 6
Feb 15, 2026 01:35AM GMT
Name
Simple
Exponential
MA5
1.313
Buy
1.319
Buy
MA10
1.309
Buy
1.318
Buy
MA20
1.324
Buy
1.325
Buy
MA50
1.349
Sell
1.359
Sell
MA100
1.426
Sell
1.412
Sell
MA200
1.525
Sell
1.465
Sell

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic1.2931.3021.3131.3221.3331.3421.353
Fibonacci1.3021.311.3141.3221.331.3341.342
Camarilla1.321.3211.3231.3221.3271.3291.331
Woodie's1.2951.3031.3151.3231.3351.3431.355
DeMark's--1.3181.3251.338--

FAQ

From a Technical Analysis Perspective, Is Pharming Group a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Do the Moving Averages for PHAR Currently Stand?

The moving averages for Pharming Group show a Strong Sell outlook, considering moving averages ranging from MA5 to MA200, with 2 Buy signals and 10 Sell signals.

What Is the Current Status of the Technical Indicators for Pharming Group?

The technical indicators for Pharming Group are in a Strong Sell position based on daily analysis, with 0 signals on buy indicators and 8 sell signals.

What Is PHAR's 14-Day RSI?

The current Relative Strength Index (RSI) of PHAR over the 14-day period is 50.233, which suggests that the stock is a Neutral.

What Is PHAR's MACD?

PHAR's MACD is -0.011, which suggests that the stock is a Sell.

What Is PHAR's 5-Day Moving Average?

PHAR's 5-day moving average is 1.313, suggesting that the stock is a Buy.

What Is PHAR's 50-Day Moving Average?

PHAR's 50-day moving average is 1.349, suggesting that the stock is a Sell.

What Is PHAR's 200-Day Moving Average?

PHAR's 200-day moving average is 1.525, suggesting that the stock is a Sell.

What Is the Fibonacci Pivot Point Performance Value for PHAR?

The Fibonacci pivot point performance value for PHAR is 1.322.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.